Patents by Inventor Thomas F. Seeger

Thomas F. Seeger has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Monoamine reuptake inhibitors for treatment of CNS disorders
    Publication number: 20040048856
    Abstract: The present invention relates to compounds that are useful exhibit activity as serotonin, norepinephrine and dopamine reuptake inhibitors, and their pharmaceutically acceptable salts, and their use in the treatment of central nervous system and other disorders.
    Type: Application
    Filed: September 4, 2003
    Publication date: March 11, 2004
    Applicant: Pfizer Inc
    Inventors: Harry R. Howard, Christopher J. Schmidt, Thomas F. Seeger, Mark L. Elliott
  • Monoamine reuptake inhibitors for treatment of CNS disorders
    Patent number: 6677378
    Abstract: The present invention relates to compounds of the formula wherein R1 through R4, X, Y, m and n are defined as in the specification. Such compounds are useful exhibit activity as serotonin, norepinephrine and dopamine reuptake inhibitors, and their pharmaceutically acceptable salts, and their use in the treatment of central nervous system and other disorders.
    Type: Grant
    Filed: April 30, 2001
    Date of Patent: January 13, 2004
    Assignee: Pfizer Inc.
    Inventors: Harry R. Howard, Jr., Christopher J. Schmidt, Thomas F. Seeger, Mark L. Elliott
  • Monoamine reuptake inhibitors for treatment of CNS disorders
    Publication number: 20020143003
    Abstract: The present invention relates to compounds of the formula 1
    Type: Application
    Filed: April 30, 2001
    Publication date: October 3, 2002
    Inventors: Harry R. Howard, Christopher J. Schmidt, Thomas F. Seeger, Mark L. Elliott
  • Neuroleptic 2-substituted perhydro-1-h-pyrido[1,2-a]pyrazines
    Patent number: 5565453
    Abstract: Antipsychotic compounds having the formula ##STR1## wherein R is hydrogen, acyl or substituted acyl; and a pharmaceutically acceptable acid addition salt thereof.
    Type: Grant
    Filed: March 24, 1994
    Date of Patent: October 15, 1996
    Assignee: Pfizer Inc.
    Inventors: Gene M. Bright, Kishor A. Desai, Thomas F. Seeger, Teresa A. Smolarek
  • Neuroleptic perhydro-1H-pyrido[1,2-a]pyrazines
    Patent number: 5157034
    Abstract: Antipsychotic compounds having the formula ##STR1## wherein Z is H or Cl; Y is O or S; n is 1-4; separately, X is H or (C.sub.1 -C.sub.2)alkyl and L is R(CH.sub.2).sub.m CO, m is 0 or 1-3, R is (C.sub.1 -C.sub.6)alkyl, (C.sub.3 -C.sub.7)cycloalkyl, phenyl, naphthyl, furyl, benzofuranyl, thienyl, benzothienyl, pyrrolyl, indolyl, isoindolyl or one of said groups substituted on aromatic or heteroaromatic ring with fluoro, chloro, (C.sub.1 -C.sub.2)alkyl or (C.sub.1 -C.sub.2)alkoxy; or together L and X, in combination with the nitrogen to which they are attached, form certain cyclic imides, 4-substituted piperidines or a cyclic sulfonamide.
    Type: Grant
    Filed: February 27, 1991
    Date of Patent: October 20, 1992
    Assignee: Pfizer Inc.
    Inventors: Gene M. Bright, Kishor A. Desai, Thomas F. Seeger